NDC 72974-415

Myfembree

Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate

Myfembree is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Myovant Sciences, Inc.. The primary component is Relugolix; Estradiol Hemihydrate; Norethindrone Acetate.

• Product ID: 72974-415_4d145097-231a-4d89-ae96-f3e86752bf7c
• NDC: 72974-415
• Product Type: Human Prescription Drug
• Proprietary Name: Myfembree
• Generic Name: Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-05-26
• Marketing Category: NDA /
• Application Number: NDA214846
• Labeler Name: Myovant Sciences, Inc.
• Substance Name: RELUGOLIX; ESTRADIOL HEMIHYDRATE; NORETHINDRONE ACETATE
• Active Ingredient Strength: 40 mg/1; mg/1; mg/1
• Pharm Classes: Estradiol Congeners [CS],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [CS],Progestin [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 72974-415-01

28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-415-01)

• Marketing Start Date: 2021-05-26
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details